Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Expert Review of Anti-Infective Therapy|November 22, 2013
Antiretroviral therapy and tuberculosis: does the regimen matter?Frank van Leth, Ferdinand W N M Wit, Sabine M Hermans
Medicine|August 9, 2019
Longitudinal virological outcomes and factors associated with virological failure in behaviorally HIV-infected young adults on combination antiretroviral treatment in the Netherlands, 2000 to 2015Annouschka M Weijsenfeld, Charlotte Blokhuis, Martijn M Stuiver, et al.
AIDS (London, England)|July 11, 2023
No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gainMyrthe L Verburgh, Ferdinand W N M Wit, Anders Boyd, et al.
The Journal of Infectious Diseases|June 29, 2002
Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapyFerdinand W N M Wit, Gerrit Jan Weverling, Jan Weel, et al.
Expert Opinion on Pharmacotherapy|April 12, 2007
Efavirenz: a reviewSaskia M E Vrouenraets, Ferdinand W N M Wit, Jacqueline van Tongeren, et al.
AIDS (London, England)|July 3, 2023
No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the NetherlandsMyrthe L Verburgh, Marc van der Valk, Bart J A Rijnders, et al.
The Journal of Infectious Diseases|November 26, 2002
CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patientsFerdinand W N M Wit, Ronald P van Rij, Gerrit Jan Weverling, et al.
AIDS (London, England)|May 18, 2023
COVID-19 in people with HIV in the NetherlandsFerdinand W N M Wit, Peter Reiss, Bart Rijnders, et al.
Open Forum Infectious Diseases|July 25, 2022
One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer InhibitorMyrthe L Verburgh, Ferdinand W N M Wit, Anders Boyd, et al.
AIDS (London, England)|June 5, 2002
Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell lossMette D Hazenberg, Sigrid A Otto, Ferdinand W N M Wit, et al.
Pageof 9